Prof. Dr. med. Claudia Denkinger
Professor of Medicine/Infectious Diseases
Access to diagnostics is poor and inequitable around the world and scarce especially in resource-limited settings. This is the case despite the fact that diagnostics are central and fundamental to quality health care for the individual as well as public health. Without diagnostics, the patient might not get treated, might get inappropriately treated or overtreated and continue to infect others. The work of our group centers around improving diagnostic solutions for vulnerable populations and enable access. We work on: Understanding need and feasibility, predicting potential, discovery and development as well as clinical and implementation studies.
Education
- MD, Medical education at Julius-Maximilians-University, Würzburg, Germany, 1997 – 2004
- Dr. med. (PhD equivalent) at Case Western Reserve University, Cleveland, Ohio & Julius-Maximilians-University, Würzburg, Germany, 2000 – 2006, In Immunology on the effects of blockade of the macrophage-migration-inhibitory factor on experimental autoimmune encephalitis
- Master of Science in Tropical Medicine and International Public Health at London School of Hygiene and Tropical Medicine, UK, 2008 – 2009
- Diploma in Tropical Medicine and Hygiene (DTM&H) from London School of Hygiene and Tropical Medicine, UK, 2009
- Resident Internal Medicine (2005-2008), Chief Medical Resident Internal Medicine (2009) and Clinical Fellow Infectious Disease (2010-2012) at Beth Israel Deaconess Medical Center, Boston, USA
- Global Health Program Co-Founder and Co-Director, Beth Israel Deaconess Medical Center, Boston, USA, 2009 - 2012
- Postdoctoral Research Fellow in Epidemiology and Biostatistics, McGill University, Montreal, Canada, 2012-2014
- Head of Hepatitis Program (2014-2016) and Head of Tuberculosis Program (2014-2019) at Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland
- Since 05/2019 head of Department Infectious Disease and Tropical Medicine Heidelberg University Hospital, Heidelberg, Germany
- Venia Legendi/Habilitation, Heidelberg University Hospital, Heidelberg, Germany about Infectious Diseases on Tuberculosis Diagnostics 2020
- Heisenberg Professorship 2023
Contributions
Projects & Grants
R2D2 TB Network – (Rapid Research in Diagnostics Development for TB Network), funded by NIH, 2020-2025
Machine learning-based tuberculosis screening tool, funded by German Alliance for Global Health Research (GLOHRA) via BMBF, 2022-2024
FIND-TB, HORIZON ERC Grants, 2024-2028
GLOBE - A hybrid effectiveness-implementation trial of innovative digital diagnostic solutions for tuberculosis in low- and middle-income countries funded by DFG, 2024-2026
BreathForDiagnosis (Breath4dx) funded by HORIZON Research and Innovation Actions, 2024-2026
B-paths HORIZON funded by Innovation Actions, 2024-2028
TSwaY (Tongue Swab Tuberculosis Diagnostic Yield Study), funded by BMGF (Bill and Melinda Gates Foundation), 2023-2024
Deutsches Zentrum für Infektionsforschung (DZIF), various projects since 2020 within TTU-TB www.dzif.de/de
Netzwerk Universitätsmedizin (NUM) www.netzwerk-universitaetsmedizin.de
- PREPARED 2022-2024
- NUM 2.0/Studiennetzwerk 2024-2025
Publications
ORCID/Research Gate URL: 0000-0002-7216-7067 (ORCID)
https://scholar.google.com/citations?user=Q65EX-UAAAAJ&hl=en